OVERVIEW

Ironing Out the Data: Iron Deficiency in Heart Failure is organized by Tarsus CNS.

Course Opens: 08/20/2024
Course Expires: 08/20/2025

Description:
CardioNerds Cofounder Dr. Amit Goyal, Chair of the CardioNerds Heart Failure Committee Dr. Jenna Skowronski, and Episode FIT Lead Dr. Shazli Khan discuss iron deficiency and its impact on heart failure with Dr. Robert Mentz, Chief of Heart Failure at Duke University and principal investigator of the HEART-FID trial. In this case-based discussion, they cover the diagnostic criteria of iron deficiency in heart failure, epidemiology, and strengths and limitations of different iron formulations.  They also review clinical trials examining the impact of iron deficiency on quality of life, heart failure hospitalizations, and mortality. Importantly, they stress the relevance of iron metabolism in heart failure, irrespective of the presence of anemia. They also discuss the approach to addressing outpatient management of iron in heart failure and future directions of research needed in this domain. 

This episode was created in collaboration with the Cardiometabolic Health Congress and is supported by an educational grant from American Regent.  All CardioNerds education is planned, produced, and reviewed by CardioNerds.

Learning Objectives:
After completing this activity, the participant should be better able to:

  • Review the prevalence and clinical burden of iron deficiency in HF patients
  • Summarize current and emerging diagnostic approaches, including clinical decision support tools, aimed to optimize the early diagnosis of ID in patients with HF
  • Interpret data about the efficacy and safety of intravenous iron repletion for the treatment of iron deficiency in HF patients
  • Summarize the guideline recommendations for the treatment of iron deficiency in patients with HF
  • Select individualized treatment regimens to manage ID in HF patients, including the administration of intravenous iron
Credits

Joint Providership Statement:
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Cardiometabolic Health Congress (CMHC) and CardioNerds.  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education:
PACE designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education:
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.

Pharmacy Continuing Education:
PACE designates this continuing education activity for 0.5 contact hours (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

For Pharmacists: Upon completing the post-test and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 – 6 weeks.

  • 0.5 AMA PRA Category 1 Credit™
  • 0.5 Contact Hours
  • 0.05 CEUs
  • TARGET AUDIENCE

    PhysicianNursingPharmacistAdvanced Practice NurseEndocrinologistsCardiologistsHealthcare ProfessionalsLipidologyAllied Health Professionals

    SPECIALITIES

    CardiologyHaematology

    RELATED ONLINE COURSES

    Webcast

    Emergency Medicine
    More actions
    US$200

    Webcast

    Pediatrics
    28 AMA PRA Category 1 Credits™
    More actions
    US$910